This inventor holds 4 USPTO granted patents. Top assignee: Kowa Company Limited. Active years: 1981-1988.
Company Filing History:
Years Active: 1981-1988
Title: Innovations of Nobuo Yokoo
Introduction
Nobuo Yokoo is a notable inventor based in Sayama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that enhance intestinal absorption of active substances. With a total of 4 patents to his name, Yokoo's work is recognized for its potential impact on medical treatments.
Latest Patents
Yokoo's latest patents include a pharmaceutical composition suitable for intestinal administration. This composition comprises a physiologically active substance with peptide bonds that is inactivable by digestive enzymes, excluding insulin, along with a synthetic chymotrypsin inhibitor. This innovative formulation is particularly designed for effective intestinal absorption of the active substance. Another notable patent involves phenyl guanidinobenzoate derivatives that exhibit protease inhibitory properties. These novel benzoyl esters demonstrate strong anti-trypsin activity, anti-thrombin activity, and anticoagulant activity with low toxicity, making them valuable for treating conditions such as pancreatitis and disseminated intravascular coagulation (DIC).
Career Highlights
Yokoo is currently associated with Kowa Company Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating pharmaceutical solutions that address critical health issues.
Collaborations
Throughout his career, Yokoo has collaborated with esteemed colleagues, including Setsuro Fujii and Masahiko Nagakura. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Nobuo Yokoo's contributions to pharmaceutical innovations highlight his dedication to improving medical treatments through research and development. His patents reflect a commitment to addressing significant health challenges, showcasing the importance of innovation in the medical field.